SPRAVATO

This brand name is authorized in Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SPRAVATO contains one active pharmaceutical ingredient (API):

1 Esketamine
UNII L8P1H35P2Z - ESKETAMINE HYDROCHLORIDE

Esketamine, the S-enantiomer of racemic ketamine, is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. Through NMDA receptor antagonism, esketamine produces a transient increase in glutamate release. Restoration of dopaminergic neurotransmission in brain regions involved in the reward and motivation, and decreased stimulation of brain regions involved in anhedonia, may contribute to the rapid response.

Read about Esketamine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SPRAVATO Nasal spray, solution FDA, National Drug Code (US) MPI, US: SPL/PLR
SPRAVATO Nasal spray, solution European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AX27 N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX27

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 514521030038705, 514521030038805, 514521030038905
Country: CA Health Products and Food Branch Identifier(s): 02499290
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 5532-MEE-1020
Country: EE Ravimiamet Identifier(s): 1809019, 1809020, 1809031, 1809042, 1840788
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 174271, 449200, 566111
Country: FR Base de données publique des médicaments Identifier(s): 67355371
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 385001, 385002, 385003
Country: HK Department of Health Drug Office Identifier(s): 67010
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8539, 8738
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1089085, 1089086, 1089087, 1089088, 1091815
Country: NL Z-Index G-Standaard, PRK Identifier(s): 207667
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 20520
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100427468
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66532001, W66532002, W66532003
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699593540011, 8699593540028, 8699593540035
Country: US FDA, National Drug Code Identifier(s): 50458-028
Country: ZA Health Products Regulatory Authority Identifier(s): 53/1.2/0732

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.